Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

Draulans, C; van der Heide, UA; Haustermans, K; Pos, FJ; van Zyp, JV; De Boer, H; Groen, VH; Monninkhof, EM; Smeenk, RJ; Kunze-Busch, M; De Roover, R; Depuydt, T; Isebaert, S; Kerkmeijer, LGW

Haustermans, K (corresponding author), Univ Hosp Leuven, Dept Radiat Oncol, Herestr 49, B-3000 Leuven, Belgium.

RADIOTHERAPY AND ONCOLOGY, 2020; 147 (): 92

Abstract

Background and purpose: Local recurrences after radiotherapy for prostate cancer (PCa) often originate at the location of the macroscopic tumour(s). S......

Full Text Link